All companies
Cooper Companies logo

What smart money is saying about Cooper CompaniesUnited States flag

COO · Healthcare · Medical - Instruments & Supplies · Market cap $16.34B

5 funds in our archive have pitched Cooper Companies — most recently The London Company Mid Cap in December 2025.

Company profile

The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, myopia, ocular dryness and eye fatigues in the Americas, Europe, Middle East, Africa, and Asia Pacific. The CooperSurgical segment focuses on family and women's health care, which provides medical devices, fertility, genomics, diagnostics, and contraception to health care professionals and patients worldwide. It offers surgical and office products, including PARAGARD, uterine manipulators, retractors, closure products, point of care products, LEEP products, endosee, and illuminate and fetal pillows; fertility products and services, such as fertility consumables and equipment, and embryo options and preimplantation genetic testing. The Cooper Companies, Inc. was founded in 1958 and is headquartered in San Ramon, California.

Fund coverage · 5 theses

  • The London Company Mid Cap
    December 2025

    Cooper Companies operates high-quality vision and women's health businesses with durable advantages and margin expansion catalysts alongside attractive valuation and activist-driven improvements.

    Read the full thesis
  • Davenport
    December 2025

    The Cooper Companies, Inc. is a leading contact lens maker with annuity-like demand, strong R&D, premium products, attractive entry valuation, insider buying, and potential value unlocks.

    Read the full thesis
  • Diamond Hill Large Cap Fund
    December 2025

    The Cooper Companies is a global leader in contact lenses and women's health poised for long-term growth and modest share gains despite near-term headwinds.

    Read the full thesis
  • Diamond Hill Long Short Fund
    September 2025

    Cooper Companies is a medical devices company with strong growth potential in contact lenses and women's health, supported by recent investments and favorable market trends.

    Read the full thesis
  • Pender US Small Mid
    March 2025

    Cooper Companies is a resilient global medical device leader in contact lenses and women's healthcare, benefiting from strong market positions and growth potential in both sectors.

    Read the full thesis

Read every full thesis on Cooper Companies

Unlock all 5 theses — the full reasoning behind what funds are buying, plus unlimited access to the entire archive.

View plans